Literature DB >> 23640093

Hearing aid tolerance after revision and obliteration of canal wall down mastoidectomy cavities.

Michael B Gluth1, Adva B Friedman, Samuel R Atcherson, John L Dornhoffer.   

Abstract

OBJECTIVE: To review the tolerance of hearing aid use after revision and obliteration of a previously unstable canal wall down mastoidectomy cavity. STUDY
DESIGN: Retrospective case series.
SETTING: Academic tertiary referral center. PATIENTS: Adults and children who underwent the described surgical procedure followed by attempted hearing aid use. INTERVENTION(S): Surgical revision and obliteration of a chronically unstable canal wall down mastoidectomy cavity and subsequent attempted use of a conventional, ear-level hearing aid. MAIN OUTCOME MEASURE(S): Stability of mastoid cavity after starting conventional hearing aid usage.
RESULTS: From a review of 87 consecutive mastoid obliteration procedures performed on previously unstable open cavities, 20 ears in 19 subjects were identified for study inclusion. The indication for hearing aid use was mixed hearing loss in the majority of subjects (85%). Among included ears, 7 (35%) had at least one documented temporary period of hearing aid nonuse because of otorrhea; however, permanent discontinuation of hearing aid use in favor of bone-anchored hearing implant placement only occurred in 3 ears (15%). The mean follow-up from the start of hearing aid use was 49 months.
CONCLUSION: Although failures do exist, attempted use of a hearing aid after revision of an unstable canal wall down mastoidectomy cavity seems feasible and generally well tolerated. However, the exact likelihood of achieving this result is yet uncertain, and hearing performance was not assessed in this study.

Entities:  

Mesh:

Year:  2013        PMID: 23640093     DOI: 10.1097/MAO.0b013e31828daeca

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  5 in total

1.  Sophono Alpha System and subtotal petrosectomy with external auditory canal blind sac closure.

Authors:  Giuseppe Magliulo; Rosaria Turchetta; Giannicola Iannella; Riccardo Valperga di Masino; Riccardo Valpega di Masino; Marco de Vincentiis
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-08       Impact factor: 2.503

2.  Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.

Authors:  Bartłomiej Król; Katarzyna Beata Cywka; Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński
Journal:  Life (Basel)       Date:  2021-04-22

3.  Hearing and hearing rehabilitation after obliteration of troublesome mastoid cavities.

Authors:  Simon Geerse; Tim J M Bost; Samira Allagul; Maarten J F de Wolf; Fenna A Ebbens; Erik van Spronsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-22       Impact factor: 2.503

4.  Hearing Rehabilitation of Patients with Chronic Otitis Media: A Discussion of Current State of Knowledge and Research Priorities.

Authors:  Douglas Backous; Byung Yoon Choi; Rafael Jaramillo; Kelvin Kong; Thomas Lenarz; Jaydip Ray; Alok Thakar; Myrthe K S Hol
Journal:  J Int Adv Otol       Date:  2022-07       Impact factor: 1.316

5.  Results of Active Middle Ear Implantation in Patients With Mixed Hearing Loss After Middle Ear Surgery: A Prospective Multicenter Study (the ROMEO Study).

Authors:  Chan Il Song; Hyong-Ho Cho; Byung Yoon Choi; Jae Young Choi; Jin Woong Choi; Yun-Hoon Choung; Jong Woo Chung; Won-Ho Chung; Sung Hwa Hong; Yehree Kim; Byung Don Lee; Il-Woo Lee; Jong Dae Lee; Jun Ho Lee; Kyu-Yup Lee; Il Joon Moon; In Seok Moon; Seung-Ha Oh; Hong Ju Park; Shi Nae Park; Ji Won Seo
Journal:  Clin Exp Otorhinolaryngol       Date:  2021-04-09       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.